Contact this trialFirst, we need to learn more about you.
Chemotherapy
Maplirpacept + Tafasitamab + Lenalidomide for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 2
Baton Rouge, Louisiana
This trial is testing 3 medicines to treat relapsed/refractory DLBCL, a type of NHL cancer, to see if they're safe & effective. Participants will receive them through IV infusion & taking a pill.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.